Saturday, December 5th, 6:30 – 8:30pm In 2010, seven of the top 20 grossing drugs in the US were cardiovascular medicines. By 2020 this...

Thursday, December 3rd: 7:30 – 9:30 pm Advances in disease stratification tools, such as molecular and imaging technologies, will help to...

Monday, December 7th: 6:30 – 9:00 pm Biological markers are increasingly accepted by the medical community as one of the major tools to...

Monday December 7th: 4:00 – 6:00 pm Iron deficiency is a common comorbidity in patients with heart failure (HF), and is associated with a...

Monday, December 7th: 1:30 – 3:30 pm Therapy for heart failure with reduced ejection fraction (HFrEF) is constantly evolving. Despite the...

Monday December 7th: 6:30 – 8:00 pm The advent of transcatheter aortic valve replacement (TAVR) constitutes a paradigm shift in the care...

Monday, December 7th: 4:00 – 6.00 pm ST-segment elevation myocardial infarction (STEMI) is a serious manifestation of coronary artery...

Monday, December 7th: 1:30 – 3:30 pm Cardiogenic shock (CS) remains the leading cause of early mortality following acute myocardial...

Sunday December 6th: 6:00 – 8:00 pm Always a difficult subject, the question, “How can we pay for this (medication, device, procedure)?”...

Sunday December 6th: 2020 3:30 – 5:30 pm Although aging itself is not a disease, it is a major risk factor for chronic diseases and...

Sunday December 6th: 1:30 – 3:30 pm Heart failure continues to represent a substantial burden among CV diseases. This has inspired...

Sunday, December 6th 6:00 – 8:30 pm Across the broad spectrum of cardiovascular (CV) diseases, chronic kidney disease (CKD) is an...

Sunday, December 6th: 3:30 – 5:30 pm Targeting the Vessels and the Heart: Oral Soluble Guanylate Cyclase Stimulator (Vericiguat) and...

Sunday, December 6th: 1:30 – 3:30 pm The Royal Society's motto “Nullius in verba” has been taken to mean “take nobody's word for it”. In...

Sunday December 6th: 6:00 – 8:00 pm Randomized trials, assessing the balance of risk of thrombotic and bleeding events after percutaneous...

Sunday, December 6th: 3:30 – 5:30 pm Continuing in the area of interventional cardiology, this session will focus on trials enrolling...

Sunday, December 6th: 1:30 – 3:00 pm Valvular heart disease (VHD) is one the most frequent pathologies treated with cardiac surgery in...

Saturday, December 5th: 4:00 – 6:00 pm and 6:30 – 9:00 pm The forum on cardiomyopathies will be presented over two sessions....

Saturday, December 5th: 1:30 – 3:30 pm iCVCT 1. Interventional Clinical Trials in the Time of COVID: Challenges for Device Studies in...

Saturday, December 5th: 1:30 – 3:30 pm, 4:00 – 6:00 pm, and 6:30 – 8:30 pm A series of three consecutive sessions will be conducted on...